普洛药业 (000739)

Apeloa Pharmaceutical Co.,Ltd.

ASZ

Tags

Contract Research Organization (CXO)Shanghai Free Trade ZonePension FundsInnovative DrugsChemical PharmaceuticalsMedical Aesthetics ConceptSynthetic BiologyBuyback PlansGuozheng Value IndexSmall Cap ValueNuclear Pollution Prevention and ControlBiological VaccinesHigh-Performing StocksShenzhen ConnectSZSE 300 IndexPharma & BiotechSZSE Defensive 50 IndexSZSE Medicine Equal Weight IndexPharmaceutical IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE Emerging Industries IndexSSE 700 Growth IndexSZSE 1000 IndexHangzhou Bay Area IndexSZSE 300 Return IndexSZSE Component Index ReturnCNI 1000 IndexCSSW Silk Road IndexCSI 500 Value Stable IndexNew Virus PreventionFTSE Russell ConceptInsurance Heavy HoldingsAntiviralSZSE Selected IndexCS High-end Manufacturing IndexSZSE Technology IndexSZSE ChiNext 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI Yangtze River Delta IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexZhaoyang 100 IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexSmall-cap Low Volatility IndexCSI 500 Growth Innovation IndexPharmaceutical 50 Strategy IndexSZSE 200 Return IndexSZSE 200 IndexYangtze River 100 IndexESG 300 IndexZhejiang 100 IndexChina Economic Index GDPCSI 1000 Value IndexSZSE 500 IndexCSI 500 ESG IndexCSI 500 Growth Valuation IndexSuyin Wealth Management Yangtze River Delta IndexCS Yangtze River Delta IndexZhejiang

K-Line Chart

No K-line data available

Company NameApeloa Pharmaceutical Co., Ltd.
Listing Date1997-05-09
Issue Price5.7RMB
Registered Capital115844.357610k RMB
Legal RepresentativeZhu Fangmeng
Registered AddressNo. 399 Jiangnan Road, Hengdian, Dongyang City, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessPharmaceutical industry investment, network investment, equity investment management, research, development, and transfer of biopharmaceutical technology, etc.
Company ProfileApeloa Pharmaceutical Co., Ltd. was founded in 1989 and entered the field of pharmaceutical R&D and production. In 2001, the company went public through an asset swap, leveraging the capital market to set sail. In 2012, the company underwent a major asset restructuring, acquiring the pharmaceutical assets of its major shareholder, achieving the overall listing of Hengdian Group's pharmaceutical industry. The company's headquarters is located in Hengdian, Zhejiang, with a registered capital of 1.178 billion yuan, total assets of 5.699 billion yuan, and over 6,000 employees, ranking among the top 50 Chinese pharmaceutical industrial enterprises. The company's main businesses are active pharmaceutical ingredients (APIs), CDMO, and formulations, each with independent R&D and marketing systems. The company operates 7 API and intermediate production plants, including 5 chemical synthesis plants and 2 biopharmaceutical fermentation plants, mainly engaged in the R&D and production of APIs and intermediates for cephalosporins, penicillins, cardiovascular and cerebrovascular drugs, veterinary drugs, psychiatric drugs, and other anti-infective and antiviral drugs. It has 4 formulation production plants with production lines for oral solid dosage forms, liquid dosage forms, lyophilized powder injections, injections, ointments, etc.; its products cover therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-infectives, and anti-tumor drugs. The company has established product R&D institutions in Hengdian, Hangzhou, Shanghai, and Chengdu; its products cover the global market, and it has established subsidiaries in the United States and Hong Kong.

Stock Details

1. Key Indicators

  • Total Shares(W): 115844.36
  • Circulating A-Shares(W): 115800.84
  • Earnings Per Share(RMB): 0.6063
  • Net Assets Per Share(RMB): 5.5992
  • Operating Revenue(W RMB): 776388.21
  • Total Profit(W RMB): 83913.95
  • Net Profit Attributable to Parent(W RMB): 70026.61
  • Net Profit Growth Rate(%): -19.48
  • Weighted Return on Equity(%): 10.21
  • Operating Cash Flow Per Share(RMB): 0.6680
  • Undistributed Profit Per Share(RMB): 4.2953
  • Capital Reserve Per Share(RMB): 0.0905

2. Main Business

The main business covers:

  • Active Pharmaceutical Ingredients (API) Intermediates
  • Innovative Drug R&D and Production Services (CDMO)
  • R&D, Production, and Sales of Drugs
  • Import and Export Trade Business

3. Company Basic Information

  • Company Name: Apeloa Pharmaceutical Co., Ltd.
  • Listing Date: 1997-05-09
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 399 Jiangnan Road, Hengdian Town, Dongyang City, Zhejiang Province, China
  • Website: www.apeloa.com
  • Company Profile: The company's predecessor was Qingdao Oriental Trade Building. In 1996, it underwent a shareholding system reform, converting its operating net assets into 32.6 million state shares, 400,000 private placement legal person shares, and 3 million internal employee shares. After the public offering in April 1997, the total share capital at the time of listing reached 63 million shares. The employee shares were scheduled to be listed six months after the 27 million public shares were listed on May 9, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hengdian Group Holding Co., Ltd. General Legal Person 33094.17 28.58
2 Zhejiang Hengdian Import & Export Co., Ltd. General Legal Person 15655.29 13.52
3 Zhejiang Hengrun Technology Co., Ltd. General Legal Person 5968.38 5.15
4 Hengdian Group Jiayuan Chemical Co., Ltd. General Legal Person 4475.02 3.86
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3499.97 3.02
6 Apeloa Pharmaceutical Co., Ltd. - Phase I Employee Stock Ownership Plan General Legal Person 2156.40 1.86
7 Dacheng Ruixiang Hybrid Securities Investment Fund Class A Fund 1874.82 1.62
8 Dacheng Gaoxin Equity Securities Investment Fund Class A Fund 1306.42 1.13
9 Dacheng Competitive Advantage Hybrid Securities Investment Fund Class A Fund 1187.07 1.03
10 Qianhai Life Insurance Co., Ltd. - Dividend Insurance Product Insurance 1002.50 0.87

5. Concept Sectors

  • Shanghai Free Trade Zone
  • Aging Care Concept
  • Industrial Internet
  • Medical Aesthetics Concept
  • CXO Concept
  • Nuclear Pollution Control
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • Pet Economy
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Share Buyback Plan
  • Pension Fund Holdings
  • Small Cap Value
  • SZSE Value Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information